Cairo – Mubasher: The board of directors of Ibnsina Pharma agreed to establish a healthcare investment company.

The pharmaceutical company is currently considering several investment opportunities in fields previously approved by the board, according to a bourse disclosure on Sunday.

In addition, the company is set to sign non-binding agreements to acquire one or several non-controlling stakes in one or several pharmaceutical companies in Egypt. 

It is worth mentioning that during the first quarter of 2020, Ibnsina Pharma posted net profits of EGP 50.27 million, up from EGP 41.97 million in the prior-year period.